These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9494864)

  • 1. Magnetic resonance spectroscopy in vivo: applications in neurological disorders.
    Arnold DL; De Stefano N
    Ital J Neurol Sci; 1997 Dec; 18(6):321-9. PubMed ID: 9494864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and applications of in vivo clinical magnetic resonance spectroscopy.
    Cox IJ
    Prog Biophys Mol Biol; 1996; 65(1-2):45-81. PubMed ID: 9029941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR spectroscopy: a powerful tool for investigating brain function and neurological diseases.
    Burlina AP; Aureli T; Bracco F; Conti F; Battistin L
    Neurochem Res; 2000 Oct; 25(9-10):1365-72. PubMed ID: 11059807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic characterization of neurological diseases by proton localized NMR spectroscopy of the human brain.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Gastaut JL; Cozzone PJ
    C R Acad Sci III; 1992; 315(7):287-93. PubMed ID: 1336428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MRS in neurological disorders.
    Bonavita S; Di Salle F; Tedeschi G
    Eur J Radiol; 1999 May; 30(2):125-31. PubMed ID: 10401593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications.
    Soares DP; Law M
    Clin Radiol; 2009 Jan; 64(1):12-21. PubMed ID: 19070693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multiparametric data analysis showing the potential of localized proton MR spectroscopy of the brain in the metabolic characterization of neurological diseases.
    Confort-Gouny S; Vion-Dury J; Nicoli F; Dano P; Donnet A; Grazziani N; Gastaut JL; Grisoli F; Cozzone PJ
    J Neurol Sci; 1993 Sep; 118(2):123-33. PubMed ID: 8229060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders.
    Rudkin TM; Arnold DL
    Arch Neurol; 1999 Aug; 56(8):919-26. PubMed ID: 10448796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications for cerebral MR proton spectroscopy in 2007].
    Galanaud D; Nicoli F; Confort-Gouny S; Le Fur Y; Ranjeva JP; Viola A; Girard N; Cozzone PJ
    Rev Neurol (Paris); 2007 Mar; 163(3):287-303. PubMed ID: 17404517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proton magnetic resonance spectroscopy in preoperative evaluation of patients with mesial temporal lobe epilepsy.
    Chernov MF; Ochiai T; Ono Y; Muragaki Y; Yamane F; Taira T; Maruyama T; Tanaka M; Iseki H; Kubo O; Okada Y; Hori T; Takakura K
    J Neurol Sci; 2009 Oct; 285(1-2):212-9. PubMed ID: 19647269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of proton MR spectroscopy in oncology.
    Kwock L; Smith JK; Castillo M; Ewend MG; Cush S; Hensing T; Varia M; Morris D; Bouldin TW
    Technol Cancer Res Treat; 2002 Feb; 1(1):17-28. PubMed ID: 12614173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proton magnetic resonance spectroscopy: a metabolic approach of cerebral tumors and their follow-up after external radiation therapy].
    Grand S; Estève F; Rémy C; Rubin C; Le Bas JF
    Rev Med Interne; 1997; 18(11):865-75. PubMed ID: 9499987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9.
    Drost DJ; Riddle WR; Clarke GD;
    Med Phys; 2002 Sep; 29(9):2177-97. PubMed ID: 12349940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-MR spectroscopy: a promising method in distinguishing subgroups in temporal lobe epilepsy?
    Hammen T; Stefan H; Pauli E; Schäfer I; Huk W; Tomandl B
    J Neurol Sci; 2003 Nov; 215(1-2):21-5. PubMed ID: 14568123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H magnetic resonance spectroscopy in multiple sclerosis and related disorders.
    Rovira A; Alonso J
    Neuroimaging Clin N Am; 2013 Aug; 23(3):459-74. PubMed ID: 23928200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical magnetic resonance spectroscopy of the central nervous system.
    Ratai EM; Gilberto González R
    Handb Clin Neurol; 2016; 135():93-116. PubMed ID: 27432661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult brain tumors: clinical applications of magnetic resonance spectroscopy.
    Brandão LA; Castillo M
    Neuroimaging Clin N Am; 2013 Aug; 23(3):527-55. PubMed ID: 23928203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR spectroscopy in diagnosis and neurological decision-making.
    Xu V; Chan H; Lin AP; Sailasuta N; Valencerina S; Tran T; Hovener J; Ross BD
    Semin Neurol; 2008 Sep; 28(4):407-22. PubMed ID: 18843570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.